The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy
Clinical trial NCT03517501 · WITHDRAWN
Trial details
- NCT number
- NCT03517501
- Sponsor
- Asahi Kasei Pharma America Corporation
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2022-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.